Antimicrobial Agents and Chemotherapy · 1983 · 27 citations · 6 references
PharmacyInfectious DiseasesPharmacotherapyAntimicrobial PharmacotherapyAntimicrobial ResistanceMedical MicrobiologyAntibacterial TherapyAntibiotic ResistanceAntimicrobial DosingBacterial InfectionsEmpiric Antimicrobial TherapyCephalosporin ResistanceCephalosporin TherapyEradicationPseudomonas Aeruginosa Infection TreatmentPseudomonas Aeruginosa ResistanceSerious Bacterial InfectionSpectrum Of CephalosporinsTreatment Of Bacterial Resistance
Ceftazidime, a new broad-spectrum cephalosporin, was administered to 30 patients with serious bacterial infections in a randomized dosing trial with daily doses of 1.5 or 3 g. Both regimens were equally efficacious, with satisfactory clinical responses in 28 instances (93%) and microbiological eradication of 79% of initial bacterial isolates. The development of resistance to ceftazidime during therapy was observed in three cases (Enterobacter agglomerans, Enterobacter cloacae, and Pseudomonas aeruginosa) and superinfection by a resistant Enterobacter agglomerans strain occurred in one case. Adverse reactions of clinical significance included one case each of leukopenia, azotemia, diarrhea (Clostridium difficile toxin positive), and rash.
6
Simplified, Accurate Method for Antibiotic Assay of Clinical Specimens
John V. Bennett, Jean L. Brodie, E. Jack Benner et al. · Applied Microbiology · 1966 · 922 citations · Full text
Harold C. Neu, P Labthavikul · Antimicrobial Agents and Chemotherapy · 1982 · 72 citations · Full text
Richard Platt, Sharon Ehrlich, J Afarian et al. · Antimicrobial Agents and Chemotherapy · 1981 · 70 citations · Full text
CEFTAZIDIME—A NEW EXTENDED-SPECTRUM CEPHALOSPORIN
David Gozzard, A. M. Geddes, I. D. Farrell et al. · The Lancet · 1982 · 54 citations
Veterinary Medicine, Infectious Diseases, Medical Microbiology +4